The aim of this study was to investigate the effects of valproate and carbamazepine, on renal glomerular and tubular functions. The patient group comprised 54 children with new-onset epilepsy treated with valproate (n = 30) and carbamazepine (n = 24). Twenty-six healthy children were in the control group. The serum creatinine and cystatin C levels and urinary excretion of N-acetyl-β-d-glucosaminidase (NAG) levels were measured and the glomerular filtration rate (GFR) was estimated. Serum creatinine and cystatin C concentrations were not different between patients and controls. The glomerular filtration rate of the patient groups were higher than those of the control group. Thus, both drugs probably lead to glomerular hyperfiltration and toxicity for glomerular functions. However, urinary N-acetyl-β-d-glucosaminidase/creatinine levels were significantly higher in patients receiving only valproate (6.1 ± 5). The difference between carbamazepine and control groups was not significant for urinary N-acetyl-β-d-glucosaminidase/creatinine levels. Our data suggest that valproate has adverse effects on renal tubular functions.
ShinnarSPellockJM. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol. 2002;17
(suppl 1):S4–S17.
2.
SerdaroğluAOzkanSAydinK. Prevalence of epilepsy in Turkish children between the ages of 0 and 16 years. J Child Neurol. 2004;19:271–274.
3.
MarsonAGWilliamsonPRHuttonJL. Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Database Syst Rev. 2000;(3):CD001030.
4.
UnayBAkinRSariciSU. Evaluation of renal tubular function in children taking antiepileptic treatment. Nephrology (Carlton). 2006,11:485–488.
5.
SkálováS. The diagnostic role of urinary N-acetyl-beta-d-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica. (Hradec Kralove)2005;48:75–80
6.
NovoMLPIzumiTYokotaKFukuyamaY. Urinary excretion of N-acetyl β-glucosaminidase and β-galactosidase by patients with epilepsy. Brain Dev. 1993;15:157–160.
7.
WatanabeKKojimaTFukudaJ. Reliability of urinary N-acetyl-β-d-glucosaminidase as an indicator of renal tubular damage in neonates. Biol Neonate. 1987;52:16–21.
8.
CsathyLOlahAVClemensB. Urinary N-acetyl-β-d-glucosaminidase in epileptic children treated with antiepileptic drugs. Arch Dis Child. 2000;83:420–422.
9.
Biomarkers for the early detection of acute kidney injury. Pediatric Nephrology Educational Feature Nephrology and Hypertension, MLC 7022, Cincinnati Children’s Hospital Medical Center.
10.
CordeiroVFPinheiroDCSilvaGBJr. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children. Clinica Chimica Acta. 2008;391:46–50.
11.
RosenthalSBökenkampAHofmannW. How to estimate GFR-serum creatinine, serum cystatin C or equations?Clin Biochem. 2007;40:153–161.
12.
SchwartzGJBrionLPSpitzerA. The use of plasma creatinine for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin N Am. 1987;34:571–590.
13.
ZappitelliMParvexPJosephL. Derivation and validation of cystatin C based prediction equations for GFR in children. Am J Kidney Dis. 2006;48:221–230.
14.
HollidayMABarrattTMAvnerED. Glomerular filtration rate, inulin clearance. In Pediatric Nephrology. 3rd ed. Baltimore, MD: Williams & Wilkins; 1994:1306.
15.
HeilbronDCHollidayMAAl-DahwiAKoganBA. Expressing glomerular filtration rate in children. Pediatr Nephrol. 1991;5:5–11.
16.
YukselACengizMSevenM. N-Acetyl-P-glucosaminidase and P-galactosidase activity in children receiving antiepileptic drugs. Pediatr Neurol. 1999;20:24–26.
17.
VerrottiAGrecoRPascarellaR. Renal tubular function in patients receiving anticonvulsant therapy: a long-term study. Epilepsia. 2000;41:1432–1435.
18.
LinbladHGBergUB. Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations. Acta Paediatr. 1994;83;418–422.
19.
SwanSK. The search continues: an ideal marker of glomerular filtration rate. Clin Chem. 1997; 43:913–914.
20.
DeinumJDerkxFHM. Cystatin C for estimation of glomerular filtration rate?Lancet. 2000;356:1624.
21.
Kyhse-AndersenJSchmidtCNordinG. Serum cystatin C, determined by rapid, automated, particle enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921–1926.
22.
KeevilBGKilpatricESNicholsSP. Biological variation of cystatin C. Implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44;1535–1539.
23.
FillerGYasinAMedeirosM. Methods of assessing renal function. Pediatr Nephrol. 2014;29:183–192.
24.
BankN. Mechanisms of diabetic hyperfiltration. Kidney Int. 1991;40:792.
PaulaRPNascimentoAFSousaSM. Glomerular filtration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC. Rev Bras Hematol Hemoter. 2013;35:349–351.
27.
SerriOBeauregardHBrazeauP. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA. 1991;265:888.
28.
HirschbergRBrunoriGKoppleJDGulerHP. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 1993;43:387.
29.
HirschbergRKoppleJD. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J Am Soc Nephrol. 1992;2:1417.
30.
AndersonSVoraJP. Current concepts of renal hemodynamics in diabetes. J Diabetes Complications. 1995;9:304–307.
31.
VervoortGVeldmanBBerdenJH. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest. 2005;35:330.
32.
CherneyDZSochettEBMillerJA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int. 2005;68:1722.
33.
PhamPTPhamPCWilkinsonAHLewSQ. Renal abnormalities in sickle cell disease. Kidney Int. 2000;57:1.
